1. Describe the mechanism and clinical impact of pharmacogenomic interactions with chemotherapy and supportive care medications
2. Discuss recent developments in pharmacogenomics of oncology care
3. Utilize clinical decision support to interpret pharmacogenomic results and integrate into the therapeutic selection process
08/11/2022 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Dyson Wake, Pharm.D.